Herpes simplex virus infection causes painful blisters on the mouth (oral herpes) or genitals (genital herpes). These infections are generally mild but can cause serious complications in people with weakened immune systems. Antiviral medications can help treat symptoms and reduce transmission. Due to the recurrence nature of the virus and absence of a cure, the treatment options mainly focus on suppressing symptoms. Nutraceuticals products such as micronutrients demonstrate potential in boosting immunity and controlling the recurrence of herpes outbreaks. The global Herpes Simplex Virus Treatment Market is estimated to be valued at US$ 2374.76 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing preference for natural and herbal treatment options are driving the demand for nutraceuticals based treatment for herpes infections. Key players are focusing on developing innovative nutraceutical formulations with antiviral properties to control herpes outbreaks and recurrence rate. Researchers are exploring antioxidants, amino acids and plant-based compounds in controlling the herpes virus. Micronutrients such as lysine restrict the virus growth by arresting the activity of an enzyme essential for virus replication. Natural products aid in symptomatic relief, enhance immunomodulation and prevent secondary infections during herpes outbreaks. Double-blind placebo-controlled clinical trials on nutraceuticals validate their efficacy and safety in managing herpes simplex virus. Segment Analysis The global Herpes Simplex Virus Treatment market is segmented based on treatment type and distribution channel. By treatment type, the market is segmented into antiviral agents, antibiotics, and others. The antiviral agents segment currently dominates the market due to the growing preference of healthcare professionals and patients for antiviral drugs such as acyclovir and valacyclovir to effectively treat HSV infections. By distribution channel, the market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The retail pharmacies segment dominates as most patients tend to purchase HSV drugs from retail pharmacies due to their widespread availability and easy accessibility. Key Takeaways The Global Herpes Simplex Virus Treatment Market Size is expected to witness high growth, exhibiting a CAGR of 5.7% over the forecast period, due to increasing prevalence of HSV infections. According to WHO, around 3.7 billion people under age 50 (67%) have HSV-1 infection globally. Regional analysis - North America is expected to dominate the global market due to rising demand for HSV treatment drugs and presence of key players in the region. The Asia Pacific region is expected to exhibit the fastest growth during the forecast period owing to increasing prevalence of HSV infections, growing awareness regarding HSV treatment options, and improving healthcare infrastructure in emerging economies. Key players - Key players operating in the Herpes Simplex Virus Treatment market are Fresenius SE & Co. KgaA, Glenmark Pharmaceuticals, Carlsbad Tech, GlaxoSmithKline PLC, Zydus Cadila, Epi Health LLC, Viatris Inc., Apotex Inc., Teva Pharmaceuticals Industries Ltd., and Emcure Pharmaceuticals Ltd (Avet Pharmaceuticals Inc.), among others. Fresenius SE & Co. KgaA, GlaxoSmithKline PLC, and Teva Pharmaceuticals Industries Ltd. currently dominate the market due to their diverse product portfolios and global market presence. Explore more information on this topic, Please visit @ https://www.newsanalyticspro.com/herpes-simplex-virus-treatment-market-trends/
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2023
Categories |